University of Ioannina
Χορήγηση ανασυνδυασμένης LH (Luteinizing hormone – ωχρινοτρόπου ορμόνης) για την ενίσχυση της δράσης του αναστολέα PDE-5 (phosphodiesterase type 5) σε άνδρες με στυτική δυσλειτουργία και χαμηλή τεστοστερόνη
Abstract
dc:descriptionTaking sildenafil orally 100 mg daily plus 125 mg recombinant LH (Luteinizing hormone -luteinizing hormone) twice a week for six weeks increases the erectile function in men witherectile dysfunction and low testosterone. After studying the data, it was found that there was adifference in graduation satisfaction with erectile function in both treatment groups (the groupafter taking the medication) with the group before treatment and it was statistically significant(p <0.001). The two groups with different treatment did not show a statistically significantdifference (p≈1.00) between them.In control of the hormones LH, FSH and testosterone before and after the combinationtherapy, the observed differences before and after treatment for the three hormones werestatistically significant. Statistical analysis of the results of sperm before and after treatmentshowed statistically significant differences in the volume of semen and sperm count for thecombination therapy with oral Sildenafil 100 mg daily and recombinant LH. Similardifferences were observed before and after treatment for the single treatment with Sildenafiloral 100 mg per day, but not statistically significant. The observed differences before and aftertreatment for the hormones LH, FSH, were not statistically significant. Satisfaction fromerectile function and level of testosterone in the observed differences before and aftertreatment was statistically significant. The statistically significant increase in testosterone aftersildenafil administration due to mechanisms of the central nervous system which were givenby the euphoria caused increased sexual contacts. The method is safe with no complicationsthan those mentioned in directives of drugs.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Semini, Gkergki
- Σεμίνη, Γκέργκι
Subjects
dc:subject × 22- Σιλδεναφίλη
- Τεστοστερόνη
- Ωοθυλακιοτρόπο ορμόνη
- Ανασυνδυασμένη ορμόνη
- Σπερμοδιάγραμμα
- Στυτική δυσλειτουργία
- Φωσφοδιεστεράση τύπου 5
- ΙΙΕΦ-5
- Sildenafil
- Testosterone
- Follice - stimulating hormone (FSH)
- Luteintzing hormone (LH)
- Sperm
- Erectile dysfunction
- Phosphodiesterase type 5
- IIEF-5
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Basic Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43590